Stock Picks of the Day: Southwest Airlines Co. (LUV), Iovance Biotherapeutics, Inc. (IOVA)

Oct 15 was a weak volume day for Southwest Airlines Co. (NYSE:LUV), with an upside momentum. The trading capacity for the firm moved to 3.32 million contracts. Over the past quarter, the average daily trading volume stood at about 4.33 million shares per day. The regular session started at $57.22 but as the trading went on, the stock escalated, ending the session with a gain of 0.52%. Its shares last traded at a price of $57.68 per share.

Southwest Airlines Co. (LUV): A -11.87% Dop In This Year — But Still Has Room To Grow 18.64%

According to 18 stock analysts, Southwest Airlines Co., is being kept at an average Outperform, rating, with at least 2.61% of shares outstanding that are currently legally short sold. The shares of the corporation went down by -7.61% during the previous month. So far this year, the stock had gone down by -11.87%. With these types of results to display analysts, are more optimistic than before, leading 13 of analysts who cover Southwest Airlines Co. (NYSE:LUV) advice their clients to include it in their buy candidate list. However, at the Wall Street, the shares for the company has been tagged a $68.43 price target, indicating that the shares will rally 18.64% from its current levels. At the moment, the stock is trading for about -13.89% less than its 52-week high.

Southwest Airlines Co. Last Posted 16.58% Sales Growth

Southwest Airlines Co. (LUV) has so far tried and showed success to beat the consensus-estimated $1.22, with their earning staying at $1.26 per share. This was revealed in their last financial report. Their revenue meanwhile grew by 16.58% from the last quarter, totaling $5.76 billion.

LUV Is -5.87% Away From SMA20

The shares of the company (LUV) staged the smart recovery as has roared back some 15.52% after stumbling to its new 52-weeks low. The share price volatility of the stock remained at 3.01% for the week and by reducing the timeframe to just a week, the volatility stood at 2.04%. As for the shares, it has gone below the 20 days moving average and is now hovering within a distance of -5.87%. Currently the price is sitting at -5.19% lower than its 50 days moving average. Analyzing the last five market sessions, the stock was able to report -4.85% losses, thus going up by 0.77%, compared with its 200-day moving average of $55.88. Also, a -2.44% overturn in Southwest Airlines Co. (LUV) witnessed over the past one year demand tendency to limit losses.

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Has 3 Buy or Better Ratings

Iovance Biotherapeutics, Inc. (IOVA) was also brought into the spotlight with a -$1.24 drop. As the regular session came to an end, the price changed by -10.39% to $10.69. The trading of the day started with the price of the stock at $11.63. However, at one point, in the middle of the day, the price touched a high of $11.8 before it finally returned some of the gains. Analyzing IOVA this week, analysts seem to be content with keeping to their bright forecast call at 1.6. Iovance Biotherapeutics, Inc. analysts gave 3 buy-equivalent recommendations, 0 sells and 0 holds. This company shares tumbled -46.28% from their most recent record high of $19.9 and now hold $854.02 million in market value of equity.

Iovance Biotherapeutics, Inc. (IOVA) Returns 33.62% This Year

The company during the last trade was able to reach a volume of 2.59 million shares. That activity is comparable to their recent volume average trend of nearly 1.34 million shares which they recorded over a period of three months. The stock price volatility for last week at the close of regular trading was 6.72%, pushing the figure for the whole month to now reaching 8.26%. Iovance Biotherapeutics, Inc. price was kept to a minimum $10.58 in intra-day trade and has returned 33.62% this year alone. At a certain point in the past four quarters, the shares traded as low as $6.6 but made a 61.97% recovery since then.